125 related articles for article (PubMed ID: 27028876)
1. First case of redness and erosion at bacillus Calmette-Guérin inoculation site after vaccination against influenza.
Kondo M; Goto H; Yamamoto S
J Dermatol; 2016 Oct; 43(10):1229-1231. PubMed ID: 27028876
[No Abstract] [Full Text] [Related]
2. Erythema at the bacillus Calmette-Guerin scar after influenza vaccination.
Chavarri-Guerra Y; Soto-Perez-de-Celis E
Rev Soc Bras Med Trop; 2019; 53():e20190390. PubMed ID: 31859956
[No Abstract] [Full Text] [Related]
3. [Hopeful vaccines: influenza and tuberculosis in reverse].
Nau JY
Rev Med Suisse; 2013 Feb; 9(373):386-7. PubMed ID: 23477075
[No Abstract] [Full Text] [Related]
4. BCG vaccine responses following simultaneous immunization against influenza and tuberculosis. 2nd report.
Zykov MP; Subbotina TI; Kaplin NN
Z Erkr Atmungsorgane; 1981 May; 157(2):165-80. PubMed ID: 6797135
[TBL] [Abstract][Full Text] [Related]
5. The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
Villanueva P; Wadia U; Crawford NW; Messina NL; Kollmann TR; Lucas M; Manning L; Richmond P; Pittet LF; Curtis N
PLoS One; 2022; 17(6):e0268042. PubMed ID: 35657850
[TBL] [Abstract][Full Text] [Related]
6. Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study.
Fletcher HA; Filali-Mouhim A; Nemes E; Hawkridge A; Keyser A; Njikan S; Hatherill M; Scriba TJ; Abel B; Kagina BM; Veldsman A; Agudelo NM; Kaplan G; Hussey GD; Sekaly RP; Hanekom WA;
BMC Med; 2016 May; 14():76. PubMed ID: 27183822
[TBL] [Abstract][Full Text] [Related]
7. Generalized bullous eruption after routine vaccination in a child with diffuse cutaneous mastocytosis.
Bankova LG; Walter JE; Iyengar SR; Lorenzo ME; Hornick JL; Castells MC
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):94-6. PubMed ID: 24229828
[No Abstract] [Full Text] [Related]
8. Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research.
Langermans JA; Andersen P; van Soolingen D; Vervenne RA; Frost PA; van der Laan T; van Pinxteren LA; van den Hombergh J; Kroon S; Peekel I; Florquin S; Thomas AW
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11497-502. PubMed ID: 11562492
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccination in children primed with MF59-adjuvanted or non-adjuvanted seasonal influenza vaccine.
Vesikari T; Forstén A; Arora A; Tsai T; Clemens R
Hum Vaccin Immunother; 2015; 11(8):2102-12. PubMed ID: 26091244
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.
Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G
Vaccine; 2015 Jan; 33(1):174-81. PubMed ID: 25444803
[TBL] [Abstract][Full Text] [Related]
11. Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine.
Gagnon R; Primeau MN; Des Roches A; Lemire C; Kagan R; Carr S; Ouakki M; Benoît M; De Serres G;
J Allergy Clin Immunol; 2010 Aug; 126(2):317-23. PubMed ID: 20579720
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity profiles of an adjuvanted seasonal influenza vaccine in Guatemalan children.
Solares AR; Aragon CG; Pivaral RU; Prado-Cohrs D; Sales-Carmona V; Pellegrini M; Groth N
J Infect Dev Ctries; 2014 Sep; 8(9):1160-8. PubMed ID: 25212080
[TBL] [Abstract][Full Text] [Related]
13. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin.
Ozeki Y; Hirayama Y; Takii T; Yamamoto S; Kobayashi K; Matsumoto S
Vaccine; 2011 Sep; 29(40):6881-7. PubMed ID: 21803102
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of adjuvanted pandemic H1N1(2009) influenza vaccine after one and two doses in young children.
Scheifele DW; Ward BJ; Dionne M; Vanderkooi O; Langley JM; Dobson S; Li Y; Law B; Halperin SA;
Pediatr Infect Dis J; 2011 May; 30(5):402-7. PubMed ID: 21178654
[TBL] [Abstract][Full Text] [Related]
15. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
Menzies D
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.
Verity C; Stellitano L; Winstone AM; Andrews N; Stowe J; Miller E
Lancet; 2011 Oct; 378(9802):1545-6. PubMed ID: 22035553
[No Abstract] [Full Text] [Related]
17. Persistent Bacillus Calmette-Guerin Reaction: A Potential Clue to Underlying Immune Deficiency.
Khalsa A; Rubin AI; Jen M
Pediatr Dermatol; 2015; 32(5):e215-6. PubMed ID: 26059661
[TBL] [Abstract][Full Text] [Related]
18. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
19. Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations.
Burt D; Mallett C; Plante M; Zimmermann J; Torossian K; Fries L
Expert Rev Vaccines; 2011 Mar; 10(3):365-75. PubMed ID: 21434804
[TBL] [Abstract][Full Text] [Related]
20. Heat-Shock Protein gp96 Enhances T Cell Responses and Protective Potential to Bacillus Calmette-Guérin Vaccine.
Ding Y; Zheng H; Feng C; Wang B; Liu C; Mi K; Cao H; Meng S
Scand J Immunol; 2016 Oct; 84(4):222-8. PubMed ID: 27417661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
